1.Occurrence and perdictive factors of radiation pneumonitis in patients with thoracic tumor
Lingli FU ; Ping LI ; Rui ZHANG ; Jianglong HAN ; Zhenming FU
Journal of International Oncology 2020;47(2):107-111
Radiation pneumonitis is a common complication in the radiotherapy for thoracic malignant tumors. And the resulting respiratory failure is one of the most serious side effects. The occurrence and severity of radiation pneumonitis depend on many factors such as age, performance status scores, smoking status, lung condition, tumor sizes, tumor location, chemoradiotherapy related factors, inflammatory factors and single-nucleotide polymorphism, et al. Some imaging examinations, for example single-photon emission computed tomography and PET-CT, have been used to predict radiation pneumonitis, while its usefulness remains to be strengthened. Further researches are still needed to find the gold standard in the prediction of radiation pneumonitis.
2.Clinical study on the level of neutrophil extracellular trap in the bile of patients with choledocholithiasis
Xin FU ; Yufang CUI ; Shaofei WANG ; Tingting JI ; Bingqing BAI ; Jianglong HONG ; Yang LI ; Junjun BAO ; Qiao MEI
Chinese Journal of Digestion 2023;43(6):371-375
Objective:To investigate the activation level of neutrophil extracellular trap (NET) in the bile of patients with choledocholithiasis and its clinical significance.Methods:From May 2021 to October 2022, 130 patients underwent endoscopic retrograde cholangiopancreatography (ERCP) at the Department of Gastroenterology, the First Affiliated Hospital of Anhui Medical University were enrolled. The patients were divided into choledocholithiasis group (90 cases) and non-choledocholithiasis group (40 cases), and the choledocholithiasis group was further divided into large stone group (maximum diameter >1 cm, 36 cases) and small stone group (maximum diameter≤1 cm, 54 cases). The bile samples were collected from 130 patients during operation and 16 choledocholithiasis patients with nasobiliary drainage at 24 h after operation.The levels of myeloperoxidase(MPO), neutrophilelastase(NE), and citrullinated histone H3(CitH3) in bile were detected by enzyme-linked immunosorbent assay.The levels of MPO, NE, and CitH3 were compared between choledocholithiasis group and non-choledocholithiasis group, between large stone group and small stone group, as well as between choledocholithiasis patients before ERCP and after ERCP. Mann-Whitney U test and Wilcoxon signed rank test were used for statistical analysis. Results:The levels of MPO, NE and CitH3 in the bile of choledocholithiasis group were 32.6 U/L(28.5 U/L), 30.6 ng/L(35.2 ng/L) and 0.37 μg/L(0.73 μg/L), respectively, which were all higher than those of non-choledocholithiasis group (19.9 U/L(36.4 U/L), 18.2 ng/L(27.4 ng/L), and 0.10 μg/L(0.25 μg/L)), and the differences were statistically significant ( Z=2.91, 3.20 and 3.34; P=0.004, 0.001 and 0.001). The levels of MPO, NE and CitH3 of large stone group were 47.0 U/L(49.4 U/L), 48.4 ng/L(39.5 ng/L) and 0.83 μg/L(1.08 μg/L), respectively, which were all higher than those of small stone group (29.3 U/L(17.5 U/L), 24.0 ng/L(25.8 ng/L), and 0.27 μg/L(0.45 μg/L)), and the differences were statistically significant ( Z=2.01, 3.58 and 3.63; P=0.044, <0.001 and <0.001). The levels of MPO, NE and CitH3 in the bile of choledocholithiasis patients after ERCP significantly decreased compare with those before ERCP (19.4 U/L(19.8 U/L) vs. 33.6 U/L(36.7 U/L), 12.7 ng/L(15.1 ng/L) vs. 22.7 ng/L(25.9 ng/L), 0.05 μg/L(0.12 μg/L) vs. 0.14 μg/L(0.27 μg/L)), and the differences were statistically significant ( Z=3.52, 3.30 and 3.18; all P<0.001). Conclusion:The activation level of NET in the bile of patients with choledocholithiasis increase, while the activation level of NET decrease after ERCP, which indicate that NET may be involved in the formation of choledocholithiasis.
3.Chinese Medicine Monomers Regulate Atherosclerosis Through NF-κB Pathway: A Review
Jianglong FU ; Xue YANG ; Wanruo WAN ; Fan ZHANG ; Xiaotao HOU ; Jiagang DENG ; Erwei HAO
Chinese Journal of Experimental Traditional Medical Formulae 2022;28(17):195-208
Cardiovascular diseases are the leading cause of death in the world today. Atherosclerosis (AS) is a chronic inflammatory disease characterized by thickening or functional degeneration of the arterial wall, and in the later stage of the disease, plaque ruptures to induce thrombosis, which in turn causes ischemia in tissues or organs. It is therefore the pathological basis for all types of cardiovascular diseases. Nuclear transcription factor kappa B (NF-κB), an important nuclear transcription factor in the inflammatory response, is activated to mediate the transcription of inflammatory factors that can trigger or exacerbate the development of AS. Vascular endothelial cells are activated by inflammatory factors. NF-κB mediates related regulatory genes in endothelial cells to secrete adhesion molecules, chemokines, and coagulation factors, promotes selective aggregation of monocytes, up-regulates the expression of adhesion molecules to make adhesion molecules stick to the endothelium and move toward the intima, promotes the degradation of the extracellular matrix, and forms unstable plaques. In recent years, traditional Chinese medicine (TCM) has achieved certain results in the prevention and treatment of AS, and many Chinese medicines have been proved to be effective in resisting AS and can act on multiple targets in the human body, affecting the occurrence and development of AS in different links. This paper mainly introduced the NF-κB pathway and its relationship with AS, reviewed research progress on 75 components of different types in Chinese medicine monomers such as flavonoids, terpenoids, and alkaloids in AS resistance based on the NF-κB pathway, and found that Chinese medicine monomers mainly regulate cholesterol balance, inhibit the inflammatory response, reduce cell proliferation, inhibit intercellular adhesion, and suppress foam cell formation by regulating the NF-κB pathway to provide a reference for the prevention and treatment of AS.